Back to results
US 9,789,092 B2Granted
Biotin for use in treating X-linked adrenoleukodystrophy
AssigneeAssistance Publique-Hopitaux de Paris
InventorFrédéric Sedel
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of biotin for treating X-linked adrenoleukodistrophy, in particular adrenomyeloneuropathy.
Claims13
A method for treating adrenomyeloneuropathy, comprising administering to a patient in need thereof a composition comprising biotin and a pharmaceutically acceptable excipient, wherein the daily amount of biotin administered to the patient is at least 250 mg.
Dependencies are inferred from the claim text.